Navigation Links
Staying One Step Ahead of Osteoporosis
Date:2/26/2009

New studies show key steps to preventing bone loss focus on early screening and treatment

LAS VEGAS, Feb. 26 /PRNewswire-USNewswire/ -- Facts about osteoporosis are staggering. 75 million baby boomers are approaching the age where the disease is tightening its grip on their bones. Osteoporosis (http://orthoinfo.aaos.org/topic.cfm?topic=A00232) also contributes to an estimated 1.5 million bone fractures in the United States annually. According to new information presented today at the 2009 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) (http://www.aaos.org/), new steps to manage bone health and increase communication, will significantly help reduce the rate of fractures and increase the quality of life for the aging population.

"Decreasing the rate of hip fractures saves lives, prevents loss of function, and decreases costs," said Tad Funahashi, MD, regional chief of orthopedic surgery and assistant area medical director for Kaiser Permanente Southern California, and clinical professor of orthopaedic surgery at the University of California Irvine's College of Medicine. "If we screen for osteoporosis at the earliest onset of the disease," said Dr. Funahashi, "we can implement treatment and help to decrease the rate of hip fractures by 45 percent." Hip Fractures and Osteoporosis Study 474 (http://www3.aaos.org/education/anmeet/anmt2009/podium/podium.cfm?Pevent=474)

Osteoporosis is also a huge problem in other parts of the world. In another study, Leonid Kandel, MD, an orthopaedic surgeon at Hadassah-Hebrew University Medical Center in Jerusalem, Israel, looked at improving the diagnosis rate of osteoporosis in post menopausal women, who fracture the distal radius bone, which is located in the lower arm, near the wrist. Dr. Kandel says these fractures are often the first clinical symptom of osteoporosis, yet only 15 to 25 percent of these women are referred for a bone density test by a family physician after the fracture.

"It is important that patients understand the connection between their current problem, the fracture, and the possibility that the underlying cause is osteoporosis." Dr. Kandel also suggests that there should be a stronger connection and better communication between the hospital and the community. He feels this will increase the number of patients who are diagnosed and treated for the disease. Osteoporosis in Women after Distal Radius Fracture Study 475 (http://www3.aaos.org/education/anmeet/anmt2009/podium/podium.cfm?Pevent=475)

Francesco Pegreffi, MD, an orthopaedic surgeon in the Department of Shoulder and Elbow Surgery at Cervesi Hospital, Cattolica, Italy, along with Lorena Belletti, MD, and Professor Maria Teresa Mascia, in the Department of Rheumatology, University of Modena, Italy, studied a group of patients, 80 percent women and 20 percent men, who were affected by rheumatoid arthritis and under Vitamin D supplementation. "We wanted to analyze the correlation between a person's age, sex, how long they had rheumatoid arthritis, whether they were taking Vitamin D supplements and whether they had fragility fractures due to osteoporosis," said Dr. Pegreffi.

"We found that women affected by rheumatoid arthritis for more than three years were osteoporotic and had a fracture risk significantly higher than those without the disease. Also, Vitamin D therapy is not enough to prevent further bone loss and fragility fractures in these patients." Men in the study faired much better. Those with rheumatoid arthritis did not have a significant risk of fracture. Risk Factors in Osteoporotic Patients Study 477 (http://www3.aaos.org/education/anmeet/anmt2009/podium/podium.cfm?Pevent=477)

Fractures, especially in adults, maybe a tip off or early warning sign, that osteoporosis could be an issue. Many of these are painful fractures of the hip, spine, wrist, arm and leg, which often occur as a result of a fall or even a simple household task. One in two women and one in five men older than 65 years old, will sustain bone fractures caused by osteoporosis.

Note: This topic will be the focus of a Media Briefing entitled: Staying One Step Ahead of Osteoporosis on Thursday, February 26, in the Sands Expo Center, Venetian Hotel, Level One, Room 904 at 10 am. Panelists include: Moderator: Kim Templeton, MD, Tad Funahashi, MD, Leonid Kandel,, MD, and Francesco Pegreffi, MD.

About AAOS

http://www6.aaos.org/news/Pemr/releases/release_boiler.cfm?category=40&releasenum=735

http://www.orthoinfo.org/

    CONTACT: Catherine Dolf
    C: (847) 894-9112 or O: (847) 384-4034
    dolf@aaos.org

    Lauren Pearson
    C: (224) 374-8610 or O: (847) 384-4031
    lpearson@aaos.org


'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
2. Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies
3. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
6. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
7. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
8. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
9. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
10. Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis
11. Phase III Data Published for Once Monthly Dose of Risedronate to Treat Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... MIRAGE, Calif. , Sept. 7, 2017  For nearly two decades, ... service in the Assisted Reproduction Insurance industry. Today, New Life Agency announces ... fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... Silicon Valley ... even on the go. Their electric toothbrushes aggressively attack oral bacteria by reducing ... sanitizing technology. Combining leading edge Enke technology with a premium timeless design, they ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving ... lost, have value to God. “Letters From Home” is the creation of published author, ... the President’s Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... and create life. Although frozen embryos have a slight statistical advantage for live ... freezing is a wonderful opportunity for women undergoing medical treatment or who are ...
(Date:9/21/2017)... ... 21, 2017 , ... With ProSlideshow Portrait from Pixel Film Studios creating a ... select from up to two layers of subject matter along with fully customizable backdrop ... Final Cut Pro X. , With ProSlideshow Portrait each user are given ...
(Date:9/21/2017)... ... 21, 2017 , ... Process Capability Indices for Medical Device ... ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing is ... Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning letter. ...
Breaking Medicine News(10 mins):